Advertisement

Related Videos

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Deborah Collyar: What's In It for Patients?

Advertisement

Advertisement




Mar
09
Today In Oncology
Partial Gland Removal May Be an Option for Many Men With Prostate Cancer
How the Cancer Moonshot Is Making a Difference for Patients Here and Across the World
Greater Plant Based Oil Lower Butter Intake Could Improve Risk of Cancer Related Mortality
Breast Cancer Mortality Rates May Have Stopped Declining
SGLT2 Inhibitors Could Help Protect Against Heart Failure in Patients With Cancer
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo